Author Archives: B Eaton

Spotlight: What Are the Side Effects of Cancer Immunotherapies?

Spotlight: What Are the Side Effects of Cancer Immunotherapies?

Immuno-oncology uses the body’s own natural defenses to combat cancer. Researchers are currently looking into several different mechanisms for training the immune system to attack cancer and bolstering its ability to kill cancerous cells. This approach to cancer treatment is a major break from the traditional treatment modalities, such as chemotherapy and radiation, which kill… Read More…

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

As new immuno-oncology therapies emerge, they are proving effective against an increasingly wide range of cancers. Importantly, immunotherapies have proven effective in treating previously intractable tumors and rare cancers. The results of continued research increasingly place immuno-oncology at the heart of new anti-cancer tactics. As researchers redouble their efforts to understand what makes the immune… Read More…

3 Approaches to Immuno-Oncology: What You Need to Know

3 Approaches to Immuno-Oncology: What You Need to Know

Traditional approaches to cancer treatment involve surgery, which is the manual removal of abnormal cells during early stages; chemotherapy, which aims to poison the abnormal cells; and irradiation, which “burns” the cells. Unfortunately, these methods are not very targeted, meaning that they also do damage to healthy cells. Older patients or those with complicating diagnoses… Read More…

AstraZeneca Partners with TapImmune for Phase 2 Ovarian Cancer Trial

AstraZeneca Partners with TapImmune for Phase 2 Ovarian Cancer Trial

As the promise of immuno-oncology grows and takes a larger foothold in the realm of cancer treatment, the competition among biotech firms—both large and small—has grown tremendously. The market has been flooded with new partnerships and acquisitions, as different organizations join forces to become the first to bring the next big drug to the market.… Read More…

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

As new immuno-oncology therapies emerge, they are proving effective against an increasingly wide range of cancers. Importantly, immunotherapies have proven effective in treating previously intractable tumors and rare cancers. The results of continued research increasingly place immuno-oncology at the heart of new anti-cancer tactics. As researchers redouble their efforts to understand what makes the immune… Read More…

We Need Better Ways to Judge Cancer Immunotherapy’s Efficacy

We Need Better Ways to Judge Cancer Immunotherapy’s Efficacy

A report in the November 1, 2015, issue of the Journal of Clinical Oncology, “Pseudoprogression and Immune-Related Response in Solid Tumors,” raised important questions about measuring the efficacy of immunotherapy in the treatment of cancer. Immuno-oncology has become a major field of research, and scientists are applying immunotherapy to the treatment of many cancers. However,… Read More…

New Clinical Trials Explore Cancer Immunotherapy Combinations

New Clinical Trials Explore Cancer Immunotherapy Combinations

As competition in the immuno-oncology field continues to ramp up, a number of biotech and pharma startups, as well as established companies, are leaping for the chance at a big payoff and an effective new cancer therapy attached to their name. Recently, oncology-focused firm TESARO, based in Waltham, Massachusetts, announced that it has commenced a… Read More…

A New Patch Delivers Immunotherapy Directly to Melanoma Tumors

A New Patch Delivers Immunotherapy Directly to Melanoma Tumors

One of the primary focuses in immuno-oncology is how to deliver treatments to make them most effective. Research on these delivery mechanisms ranges from biological markers and personalized medicine to mechanical methods. While immunotherapy has proven especially effective for some patients, others may see little or no benefit, which has spurred researchers to figure out… Read More…

Johns Hopkins Opens New Cancer Immunotherapy Institute

Johns Hopkins Opens New Cancer Immunotherapy Institute

A number of exciting programs at leading companies and research institutions have emerged exploring the potential of immuno-oncology. In March, Johns Hopkins University in Baltimore announced the inception of its Bloomberg-Kimmel Institute for Cancer Immunotherapy, which purportedly embraces the “moonshot” of the Obama administration to cure cancer. The center is funded by two $50 million… Read More…

Immuno-Oncology – What Do People Want to Know?

Immuno-Oncology – What Do People Want to Know?

Cancer immunotherapy is a field that has seen remarkable growth in the past decade. This growth is largely driven by some incredible stories of success. While immuno-oncology’s potential to provide treatments for even the most intractable cancers is high, a number of questions still exist, from exactly how to apply insights in the clinical setting… Read More…